Poseida Therapeutics holds virtual R&D Day

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on PSTX:

• Poseida Therapeutics Reports Strong Q3 2024 Progress
• Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
• Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
• Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration
• Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1